Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001199146 | SCV001370142 | uncertain significance | Rhabdoid tumor predisposition syndrome 2 | 2019-05-09 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: BP4. |
Gene |
RCV001586038 | SCV001813590 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001199146 | SCV002382890 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258153 | SCV002532803 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-02 | criteria provided, single submitter | curation |